NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

This is verifiably false.

“Clinically appropriate” means that the trial treated the human participants as human and not as lab rats.

Regarding the landmark P3, the FDA would argue that the GBM patients were not lab rats, and the crossover design was necessary.





Skip to timestamp 8:01. Dr. Liau again confirms that the crossover was mandated by the FDA.
https://edhub.ama-assn.org/jn-learning/audio-player/18738384


https://www.annalsofoncology.org/article/S0923-7534(22)00006-0/fulltext

If you like traditional placebo trials, then you’ll love the PD1 combo trial. This trial doesn’t require crossover because all of the placebo participants have access to an efficacious therapy (100% of the placebo control group are receiving DCVax-L):

https://clinicaltrials.gov/ct2/show/NCT04201873





https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847